New data from Vimpat ® (lacosamide) CV showed sustained efficacy for up to five years, improving seizure new control over data term … When showed that Vimpat ® CV always sustained reduction in seizure frequency for up to five years when used as adjuvant therapy in patients uncontrolled partial seizures in adults with epilepsy.
Photosensitive Drug Reactions